We continue our series on capital relief trades (CRTs) with a look at issues that arise under the Volcker Rule and U.S. risk retention rules in connection with structuring CRTs in the U.S.

Please be on the look-out for Part three of our CRT series in which Ed Parker, global practice head of Derivatives & Structured Products at Mayer Brown will provide a UK perspective on CRTs, including the capital treatment and regulatory requirements for such transactions and the insurance and swap issues arising in connection with CRTs issued in the United Kingdom, as well as the European Banking Authority’s consultation paper on an STS framework for synthetic securitizations.

You can find Part two of our CRT series here.

In case you missed it, please check out Part one of the series (found here), featuring:

  • Julie Gillespie, co-head of Mayer Brown’s structured finance practice, and Carol Hitselberger, co-leader of Mayer Brown’s banking and finance practice, discussing why U.S. banks are interested in CRT and what are the operational requirements for synthetic securitizations under the U.S. capital rules;
  • Larry Hamilton, co-lead of Mayer Brown’s US Insurance Regulatory & Enforcement group discussing issues that arise under U.S. insurance regulations in connection with CRTs; and
  • Derivatives partners, Curtis Doty and Matt Kluchenek, discussing important issues under swaps regulations affecting CRTs in the U.S.